Tuesday
Jan032012
SMART:SCOTLAND Award
Tuesday, January 3, 2012 at 11:21AM Aquila BioMedical is very pleased to announce the receipt of SMART:SCOTLAND funding for the purpose of developing the innovative MBP-tracker model. This technology will provide opportunity to the Pharmaceutical Industry to gain access to high value mechanism of action tools which will be relevant to the investigation of a range of T cell mediated autoimmune diseases, including Multiple Sclerosis. We look forward to discussing this with interested parties.


Reader Comments